Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
grade F 15.22 -3.79% -0.60
ASMB closed down 3.79 percent on Friday, May 17, 2019, on 59 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ASMB trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -3.79%
Bollinger Band Squeeze Range Contraction -3.79%
180 Bearish Setup Bearish Swing Setup -4.64%
20 DMA Support Bullish -4.64%
Bollinger Band Squeeze Range Contraction -4.64%
NR7 Range Contraction -4.64%
Inside Day Range Contraction -4.64%
20 DMA Support Bullish -7.48%

Older signals for ASMB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.
Medicine Medical Specialties Gastroenterology Digestive System Digestive System Surgery Large Intestine Fecal Incontinence Gastrointestinal Products
Is ASMB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.91
52 Week Low 13.13
Average Volume 384,822
200-Day Moving Average 24.8838
50-Day Moving Average 17.7186
20-Day Moving Average 15.8655
10-Day Moving Average 16.174
Average True Range 1.1344
ADX 20.43
+DI 16.9308
-DI 25.139
Chandelier Exit (Long, 3 ATRs ) 14.3368
Chandelier Exit (Short, 3 ATRs ) 17.6032
Upper Bollinger Band 16.8307
Lower Bollinger Band 14.9003
Percent B (%b) 0.17
BandWidth 12.167281
MACD Line -0.5319
MACD Signal Line -0.6252
MACD Histogram 0.0933
Fundamentals Value
Market Cap 264.28 Million
Num Shares 17.4 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -5.19
Price-to-Sales 176.68
Price-to-Book 9.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.36
Resistance 3 (R3) 16.40 16.06 16.17
Resistance 2 (R2) 16.06 15.77 16.04 16.11
Resistance 1 (R1) 15.64 15.59 15.47 15.60 16.04
Pivot Point 15.30 15.30 15.22 15.28 15.30
Support 1 (S1) 14.88 15.01 14.71 14.84 14.40
Support 2 (S2) 14.54 14.83 14.52 14.33
Support 3 (S3) 14.12 14.54 14.27
Support 4 (S4) 14.08